TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 47.83%-331.89M | ---- | 58.67%-636.18M | ---- | -62.30%-1.54B | ---- | -27.02%-948.5M | ---- | 18.22%-746.72M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -0.99%-200.99M | ---- | 6.46%-199.03M | ---- | -22.41%-212.78M | ---- | 32.01%-173.82M | ---- | -26.62%-255.65M |
Investment loss (gain) | ---- | 44.86%-20.56M | ---- | 44.33%-37.29M | ---- | ---66.98M | ---- | ---- | ---- | ---- |
Attributable subsidiary (profit) loss | ---- | -100.38%-251K | ---- | 71.05%66.32M | ---- | -68.19%38.77M | ---- | 344.40%121.9M | ---- | 539.67%27.43M |
Impairment and provisions: | ---- | -49.24%49.04M | ---- | 335.98%96.61M | ---- | -28.42%22.16M | ---- | 35.75%30.96M | ---- | 1,237.42%22.8M |
-Impairmen of inventory (reversal) | ---- | 129.22%12.85M | ---- | --5.61M | ---- | ---- | ---- | ---- | ---- | ---- |
-Other impairments and provisions | ---- | -60.23%36.19M | ---- | 310.68%91M | ---- | -28.42%22.16M | ---- | 35.75%30.96M | ---- | 1,237.42%22.8M |
Revaluation surplus: | ---- | 22.71%-101M | ---- | -177.19%-130.68M | ---- | -201.86%-47.15M | ---- | 71.80%-15.62M | ---- | -86.55%-55.39M |
-Other fair value changes | ---- | 22.71%-101M | ---- | -177.19%-130.68M | ---- | -201.86%-47.15M | ---- | 71.80%-15.62M | ---- | -86.55%-55.39M |
Asset sale loss (gain): | ---- | 95.82%-11.54M | ---- | -45,660.43%-276.39M | ---- | 80.92%-604K | ---- | 90.77%-3.17M | ---- | ---34.3M |
-Loss (gain) from sale of subsidiary company | ---- | ---984K | ---- | ---- | ---- | ---5.09M | ---- | ---- | ---- | ---34.3M |
-Loss (gain) on sale of property, machinery and equipment | ---- | 36.66%1.66M | ---- | -72.99%1.21M | ---- | --4.48M | ---- | ---- | ---- | ---- |
-Loss (gain) from selling other assets | ---- | 95.60%-12.21M | ---- | ---277.6M | ---- | ---- | ---- | ---3.17M | ---- | ---- |
Depreciation and amortization: | ---- | -15.46%160.78M | ---- | -8.10%190.18M | ---- | 21.89%206.94M | ---- | 16.52%169.78M | ---- | 227.38%145.71M |
-Depreciation | ---- | -15.46%160.78M | ---- | -8.10%190.18M | ---- | 21.89%206.94M | ---- | 16.52%169.78M | ---- | 227.38%145.71M |
Exchange Loss (gain) | ---- | 100.44%150K | ---- | -188.34%-33.88M | ---- | -89.57%38.35M | ---- | 1,016.13%367.69M | ---- | 74.32%-40.14M |
Special items | ---- | -62.40%29.11M | ---- | -18.80%77.43M | ---- | 46.72%95.36M | ---- | -29.21%64.99M | ---- | -27.68%91.81M |
Operating profit before the change of operating capital | ---- | 51.62%-427.16M | ---- | 39.75%-882.91M | ---- | -279.82%-1.47B | ---- | 54.31%-385.8M | ---- | 25.35%-844.45M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | -76.50%34.41M | ---- | 161.63%146.43M | ---- | -177.27%-237.61M | ---- | -136.75%-85.7M | ---- | ---36.2M |
Accounts receivable (increase)decrease | ---- | 272.16%346.85M | ---- | 115.18%93.2M | ---- | -1.99%-613.85M | ---- | -97.53%-601.89M | ---- | -671.69%-304.71M |
Accounts payable increase (decrease) | ---- | -38.45%-223.59M | ---- | -116.11%-161.49M | ---- | 3,571.45%1B | ---- | -104.24%-28.89M | ---- | 696.68%681.15M |
Special items for working capital changes | ---- | -10,747.83%-9.8M | ---- | 100.12%92K | ---- | ---75.09M | ---- | ---- | ---- | ---- |
Cash from business operations | -105.63%-134.69M | 65.29%-279.29M | 21.83%-65.5M | 42.07%-804.68M | 73.31%-83.79M | -26.52%-1.39B | 12.35%-314M | -123.19%-1.1B | 28.93%-358.23M | 54.63%-491.95M |
Other taxs | 82.20%-313K | 39.77%-3.57M | 62.81%-1.76M | 57.17%-5.93M | -34.37%-4.73M | -223.41%-13.86M | -180.10%-3.52M | 65.03%-4.28M | 9.83%-1.26M | -1,437.26%-12.25M |
Special items of business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 65.03%-4.28M | ---- | -1,437.26%-12.25M |
Adjustment items of business operations | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -65.03%4.28M | ---- | 1,437.26%12.25M |
Net cash from operations | -100.72%-135.01M | 65.11%-282.86M | 24.01%-67.26M | 42.22%-810.62M | 72.12%-88.52M | -27.28%-1.4B | 11.67%-317.52M | -118.62%-1.1B | 28.88%-359.48M | 53.54%-504.2M |
Cash flow from investment activities | ||||||||||
Interest received - investment | 464.39%237.72M | -10.19%64.59M | 916.39%42.12M | --71.92M | -90.80%4.14M | ---- | -11.93%45.02M | -62.84%93.38M | -71.40%51.12M | 3,772.53%251.25M |
Dividend received - investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --2.32M | ---- | ---- |
Restricted cash (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---76.08M | ---- | ---- | ---- |
Decrease in deposits (increase) | 215.36%1.58B | -407.61%-2.09B | ---1.37B | 76.21%-411.61M | ---- | -476.67%-1.73B | -460.70%-1.68B | -103.74%-300M | -105.43%-300M | 200.14%8.02B |
Sale of fixed assets | 149.19%618K | 1,388.00%2.6M | 264.71%248K | -84.69%175K | --68K | --1.14M | ---- | ---- | ---- | 1,147.55%1.78M |
Purchase of fixed assets | 38.52%-10.54M | -24.75%-42.96M | -38.37%-17.14M | 61.37%-34.44M | 65.86%-12.39M | -21.85%-89.15M | -47.84%-36.28M | 45.00%-73.17M | 47.53%-24.54M | 32.70%-133.02M |
Sale of subsidiaries | ---- | -97.12%11.39M | --10.39M | --395.67M | ---- | ---- | ---- | ---- | ---- | ---118.65M |
Acquisition of subsidiaries | ---- | 128.76%180.14M | ---69.94M | -31,568.91%-626.41M | ---- | ---1.98M | ---- | ---- | ---- | ---9.87M |
Recovery of cash from investments | 16.91%6.01B | -46.80%8.91B | -20.00%5.14B | -15.36%16.75B | -44.13%6.42B | 258.26%19.78B | 267.06%11.5B | 192.09%5.52B | 344.16%3.13B | 34.46%1.89B |
Cash on investment | -136.58%-6.52B | 40.95%-8.52B | 53.66%-2.75B | 31.49%-14.43B | 56.17%-5.94B | -171.90%-21.06B | -317.30%-13.56B | -42.75%-7.75B | -230.24%-3.25B | -199.65%-5.43B |
Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --5.2M | --5.2M | ---- |
Net cash from investment operations | 31.54%1.3B | -186.90%-1.49B | 108.48%984.55M | 155.16%1.71B | 112.39%472.26M | -24.16%-3.1B | -889.18%-3.81B | -155.78%-2.5B | -107.18%-385.42M | 146.84%4.48B |
Net cash before financing | 26.47%1.16B | -296.66%-1.77B | 139.04%917.29M | 119.97%899.47M | 109.29%383.74M | -25.11%-4.5B | -454.44%-4.13B | -190.61%-3.6B | -115.33%-744.9M | 137.33%3.97B |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | --10.5M | --10.5M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Refund | ---- | ---4M | ---4M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Issuing shares | -96.50%161K | 701.49%4.86M | -9.54%4.61M | -99.64%606K | -93.09%5.09M | -97.61%167.12M | 553.86%73.64M | 9,119.41%7B | --11.26M | -98.93%75.97M |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | 38.53%-226.13M | ---226.13M | ---367.86M | ---- | ---- | ---- | ---- |
Other items of the financing business | ---- | ---- | ---- | ---- | ---- | ---10.04M | ---- | ---- | ---- | ---- |
Net cash from financing operations | 34.78%-18.74M | 78.81%-67.36M | 89.11%-28.73M | 0.63%-317.88M | -1,213.87%-263.97M | -104.62%-319.91M | 183.10%23.7M | 78,337.16%6.92B | 4.85%-28.52M | -99.87%8.83M |
Effect of rate | -86.37%819K | -96.13%2.1M | -47.45%6.01M | 268.65%54.23M | 132.67%11.44M | 91.26%-32.15M | -238.78%-35.01M | -737.18%-367.69M | -37.46%25.23M | 239.12%57.71M |
Net Cash | 28.45%1.14B | -415.74%-1.84B | 641.89%888.56M | 112.06%581.59M | 102.92%119.77M | -245.17%-4.82B | -430.93%-4.11B | -16.54%3.32B | -116.01%-773.42M | 209.78%3.98B |
Begining period cash | -49.56%1.87B | 20.75%3.7B | 20.75%3.7B | -61.30%3.06B | -61.30%3.06B | 59.51%7.92B | 59.51%7.92B | 435.95%4.97B | 435.95%4.97B | -79.84%926.49M |
Cash at the end | -34.53%3.01B | -49.56%1.87B | 43.78%4.6B | 20.75%3.7B | -15.43%3.2B | -61.30%3.06B | -10.39%3.78B | 59.51%7.92B | -27.24%4.22B | 435.95%4.97B |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.